Curative Biotechnology Inc (CUBT)

[Wrangler1]

Apparently the market doesn’t care too much about the terms. The stock price is exactly where it was when I added last week. It sounds like to me you place zero value on the worldwide license CUBT has to a Metformin eye drop treatment for AMD, the initiative of which is being lead by Dr. Bharti who works at the National Eye Institute (part of the National Health Institute) and is an Advisor to CUBT management on its development. I am thinking more people are more intrigued by this potential than the terms of a short term loan to fund their research which is needed to advance to the product stage eventually.